Buscar resultados de ensayos clínicos
Myasthenic Syndromes, Congenital - 11 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes Condición: Myasthenic Syndromes, Congenital Fecha: 2015-09-24 Intervenciones:
|
Recruiting |
Nombre del estudio: Ephedrine for the Treatment of Congenital Myasthenia Condición: Myasthenic Syndromes, Congenital Fecha: 2007-10-07 Intervenciones: Drug: Ephedrine |
Completed |
Nombre del estudio: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condición: Congenital Myasthenic Syndrome Fecha: 2010-09-15 Intervenciones: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
Nombre del estudio: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condición:
|
Recruiting |
Nombre del estudio: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) Condición:
|
Available |
Nombre del estudio: Treatment Use of 3,4-Diaminopyridine Condición:
|
Available |
Nombre del estudio: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) Condición:
|
Available |
Nombre del estudio: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Condición:
|
Completed |
Nombre del estudio: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condición: Congenital Myasthenic Syndrome Fecha: 2011-11-16 |
No longer available |
Nombre del estudio: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condición: Lambert Eaton Myasthenic Syndrome (LEMS) Fecha: 2011-06-20 Intervenciones: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |